Evidence map›Paper›PMID 38456219›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

Sharp increase in gonorrhoea notifications among young people, EU/EEA, July 2022 to June 2023.

Lina Nerlander, Lydia Champezou, Joana Gomes Dias, Gudrun Aspelund, Lina Berlot, Elisavet Constantinou, Asunción Díaz, Jevgenia Epštein, Erika Fogarassy, Victoria Hernando and 20 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. JAC-antimicrobial resistance · 2026
    Article
  2. Article
  3. Observational
  4. Decreased chlamydia notifications in six European Union/European Economic Area countries and England, 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Open forum infectious diseases · 2026
    Article
  10. Article
  11. Estimated effect of reduced asymptomatic testing on missedThe Lancet regional health. Europe · 2025
    Article
  12. Article
  13. Antimicrobial resistance inThe Lancet regional health. Europe · 2025
    Article
  14. Review
  15. Article
  16. Increase inSexually transmitted infections · 2025
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Lina NerlanderEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Lydia ChampezouEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Joana Gomes DiasEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Gudrun AspelundCentre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland.
Lina BerlotCommunicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
Elisavet ConstantinouMinistry of Health, Nicosia, Cyprus.
Asunción DíazNational Centre of Epidemiology, CIBER in Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.
Jevgenia EpšteinDepartment of Communicable Diseases Epidemiology Health Board, Tallinn, Estonia.
Erika FogarassyNational Center for Public Health and Pharmacy, Budapest, Hungary.
Victoria HernandoNational Centre of Epidemiology, CIBER in Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.
Patrick HoffmannHealth Directorate Luxembourg, Division de l'inspection sanitaire, Luxembourg, Luxembourg.
Derval IgoeHSE Public Health: National Health Protection Office, Dublin, Ireland.
Irena KlavsCommunicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
Pedro Pinto LeiteDirectorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.
Kirsi LiitsolaFinnish Institute for Health and Welfare, Helsinki, Finland.
Angeline McIntyreHSE Public Health: National Health Protection Office, Dublin, Ireland.
Zsuzsanna MolnárNational Center for Public Health and Pharmacy, Budapest, Hungary.
Anne Olaug OlsenDepartment of Infection Control and Vaccine, Norwegian Institute of Public Health, Oslo, Norway.
Yolanda Pires-AfonsoHealth Directorate Luxembourg, Division de l'inspection sanitaire, Luxembourg, Luxembourg.
Renāte PutniņaThe Centre for Disease Prevention and Control, Riga, Latvia.
Kęstutis RudaitisNational Public Health Centre, Vilnius, Lithuania.
Georgios SiakallisGrigorios HIV Clinic, Larnaca General Hospital, Larnaca, Cyprus.
Sacha de StoppelaarRijksinstituut voor Volksgezondheid en Milieu, Bilthoven, the Netherlands.
Barbara SuligoiNational AIDS Unit, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Tuula Hannila-HandelbergFinnish Institute for Health and Welfare, Helsinki, Finland.
Inga VelickoPublic Health Agency of Sweden, Stockholm, Sweden.
Vítor Cabral VeríssimoDirectorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.
Maartje VisserRijksinstituut voor Volksgezondheid en Milieu, Bilthoven, the Netherlands.
Maria WessmanDepartment of Infectious Disease Epidemiology and Prevention Statens Serum Institut, Copenhagen, Denmark.
Otilia MårdhEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gonorrhoea cases increased steeply in women aged 20 to 24 years across 15 EU/EEA countries in July to December 2022 and January to June 2023 with, respectively, 73% and 89% more cases reported than expected, based on historical data from 2015 to 2019. Smaller increases among men due to heterosexual transmission were observed in nine EU/EEA countries. Interventions to raise awareness among young people about sexually transmitted infection risks are needed, emphasising the benefit of safe sexual practices and testing.

Indexed as

GonorrheaSexually Transmitted DiseasesAdolescentFemaleHeterosexualityHumansMaleSexual Behaviorcondom useCOVID-19Gonorrhoeasexual behaviourSTItesting

Identifiers

PMID38456219
PMCPMC10986672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.